Global Refractive surgery devices Market is valued at approximately USD 195.1 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2022-2029. Refractive surgery devices are medical instruments used to correct refractive errors in the eye, such as nearsightedness, farsightedness, and astigmatism. Refractive surgery devices work by reshaping the cornea, the clear front part of the eye, to improve the way that light is focused on the retina, which can improve vision. There are several types of refractive surgery devices, including laser-based devices such as LASIK (Laser-Assisted In Situ Keratomileusis), PRK (Photorefractive Keratectomy), and SMILE (Small Incision Lenticule Extraction), as well as non-laser devices such as ICL (Implantable Collamer Lens) and RLE (Refractive Lens Exchange). These devices are used by ophthalmologists and refractive surgeons who have specialized training and expertise in performing refractive surgery procedures. Refractive surgery can be an effective way to correct vision problems and improve the quality of life for many people who are good candidates for the procedure. The key factor driving the market growth is the growing rate of refractive errors and other eye conditions, such as myopia, astigmatism, hyperopia, and others also growing technological advances in refractive surgery devices are anticipated to support the market growth during the forecast period.

However, the rising cases of myopia, also known as nearsightedness, is one of the factors that is driving the growth of the refractive surgery devices market. Myopia is a common condition that affects a large percentage of the global population, and it is projected to continue to increase in prevalence in the coming years. This increase in myopia cases is due in part to factors such as changing lifestyles and increased screen time. According to The International Myopia Institute, the prevalence of myopia in 2010 was 2 billion, the number reached 2.6 billion in 2020 and is anticipated to reach 4.8 billion by 2050. As a result, the rising cases of myopia are anticipated to support market growth. Additionally, rising healthcare expenditure and growing investment in healthcare sector is anticipated to create a lucrative opportunity for the market during the forecast period. However, the high cost of Refractive surgery devices stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Refractive surgery devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, the high incidence of refractive errors, and the availability of effective reimbursement policies. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as rising geriatric and target populations, increasing myopia cases, and rising healthcare expenditures in the region would create lucrative growth prospects for the Refractive surgery devices market.

Major market player included in this report are:
Johnson & Johnson Services, Inc.
Carl Zeiss Meditec AG
Alcon
Bausch & Lomb Incorporated
Quantel Medical
TOPCON CORPORATION
Essilor International
NIDEK CO., LTD.
SCHWIND eye-tech-solutions Gmbh
LENSAR Inc.

Recent Developments in the Market:
In Feb. 2019, Johnson & Johnson Vision announced the launch of TECNIS Eyhance intraocular lenses in the Europe market. The new intraocular lenses are next-generation lenses that can provide effectiveness in intermediate and far distances.

Global Refractive surgery devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Application, Product, End-use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Myopia
Hyperopia
Astigmatism
Presbyopia
Dry Eyes

By Product:
Lasers
Microkeratome
Aberrometers
Others

By End-use:
Hospitals
Ambulatory Surgery Centers
Ophthalmology Clinics

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World